Although no statistical significance was identified, combination of VKA and SAPT treatment showed a trend toward achieving the greatest beneficial effect compared to other regimens, followed by rivaroxaban 2.5 mg twice daily with DAPT.
← all excerpts
Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis.
1
—
—